These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36155847)

  • 1. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study.
    Martínez-Solano J; Ortiz-Bautista C; Gutiérrez-Ibañes E; García-Cosío MD; Sarnago-Cebada F; Díaz-Molina B; Pascual I; Gómez-Bueno M; Calviño-Santos R; Gómez-Hospital JA; García-Lara J; de la Fuente-Galán L; Mirabet-Pérez S; Martínez-Sellés M
    Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):312-321. PubMed ID: 36155847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the optical coherence tomography observation of pulmonary ultra-structural changes in heart failure (OCTOPUS-CHF) study.
    Ortiz-Bautista C; Gutiérrez-Ibañes E; García-Cosío MD; Calviño-Santos R; Gómez-Bueno M; Mirabet-Pérez S; Gómez-Hospital JA; Lambert-Rodríguez JL; Garrido-Bravo IP; de la Fuente Galán L; Mombiela T; Martínez-Solano J; Martínez-Sellés M
    Int J Cardiol; 2020 Jan; 299():296-300. PubMed ID: 31278027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Vascular Remodeling and Prognosis in Patients Evaluated for Heart Transplantation: Insights from the OCTOPUS-CHF Study.
    Martínez-Solano J; Gutiérrez-Ibañes E; Ortiz-Bautista C; García-Cosío MD; Sarnago-Cebada F; Díaz-Molina B; Pascual I; Oteo-Domínguez JF; Gómez-Bueno M; Calviño-Santos R; Crespo-Leiro MG; Gómez-Hospital JA; Díez-López C; García-Lara J; Garrido-Bravo IP; de la Fuente-Galán L; López-Díaz J; Mirabet-Pérez S; Martínez-Sellés M
    J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography for hypertensive pulmonary vasculature.
    Jiang X; Peng FH; Liu QQ; Zhao QH; He J; Jiang R; Wang L; Xu XQ; Li JH; Ebrahimi R; Jing ZC
    Int J Cardiol; 2016 Nov; 222():494-498. PubMed ID: 27505340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure.
    Lanzarini L; Fontana A; Lucca E; Campana C; Klersy C
    Am Heart J; 2002 Dec; 144(6):1087-94. PubMed ID: 12486435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic profiles in a series of patients undergoing right heart catheterization. Experience in one center of Medellin, Colombia.
    Castaño-Cifuentes O; Clavijo-Moldón AA; Díaz-Betancur JS
    Arch Cardiol Mex; 2022; 92(1):53-59. PubMed ID: 34987239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients.
    Stein JH; Neumann A; Preston LM; Costanzo MR; Parrillo JE; Johnson MR; Marcus RH
    J Am Coll Cardiol; 1997 Dec; 30(7):1765-72. PubMed ID: 9385905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension.
    Maron BA; Kleiner DE; Arons E; Wertheim BM; Sharma NS; Haley KJ; Samokhin AO; Rowin EJ; Maron MS; Rosing DR; Maron BJ
    Chest; 2023 Mar; 163(3):678-686. PubMed ID: 36243062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of right ventricular function in advanced heart failure with nonischemic dilated cardiomyopathy: insights of right ventricular elastance.
    Bianco F; Bucciarelli V; Ammirati E; Occhi L; Musca F; Tonti G; Frigerio M; Gallina S
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):134-143. PubMed ID: 31923053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
    Covella M; Rowin EJ; Hill NS; Preston IR; Milan A; Opotowsky AR; Maron BJ; Maron MS; Maron BA
    Circ Heart Fail; 2017 Apr; 10(4):e003689. PubMed ID: 28396501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.
    Lanzarini L; Fontana A; Campana C; Klersy C
    J Heart Lung Transplant; 2005 Jun; 24(6):745-54. PubMed ID: 15949736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Area and Right Ventricle Dimensions in Non-gated Axial Chest CT can Differentiate Pulmonary Hypertension Due to Left Heart Disease from Other Causes.
    Katikireddy CK; Singh M; Muhyieddeen K; Acharya T; Ambrose JA; Samim A
    J Cardiovasc Comput Tomogr; 2016; 10(3):246-50. PubMed ID: 26869368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation.
    Chaix MA; Ibrahim R; Tardif JC; Roy C; Mongeon FP; Dore A; Mondésert B; Khairy P
    Expert Rev Cardiovasc Ther; 2024; 22(4-5):153-158. PubMed ID: 38477934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility.
    Colin GC; Verlynde G; Pouleur AC; Gerber BL; Beauloye C; Kefer J; Coche E; Vachiéry JL; Gevenois PA; Ghaye B
    Eur Radiol; 2020 Nov; 30(11):6204-6212. PubMed ID: 32548647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary artery wall thickness in children with Fontan physiology: an optical coherence tomography case control study.
    McGovern E; Voss C; Brunner NW; Duncombe S; Harris KC; Hosking MH
    Cardiol Young; 2019 Apr; 29(4):524-527. PubMed ID: 30957731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
    JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.
    Swift AJ; Rajaram S; Hurdman J; Hill C; Davies C; Sproson TW; Morton AC; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1036-1047. PubMed ID: 23769494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.